TherapeuticsMD (TXMD) Operating Leases (2019 - 2026)
TherapeuticsMD (TXMD) reported Operating Leases of $4.52 million for Q2 2026, down 20.9% from $5.72 million a year earlier and down 6.3% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD posted Operating Leases of $5.12 million, down 7.6% from FY2024.
- Operating Leases has declined for six consecutive years, with a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
- By year, Operating Leases came in at $5.54 million in FY2024 (-15.2%), $6.53 million in FY2023 (-11.4%), $7.37 million in FY2022 (-8.6%) and $8.06 million in FY2021 (-7.1%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases since Q2 2019.
- Year over year, Operating Leases has now declined in each of the last four quarters, with an average decline of 13.9% over the last six quarters.
- The year-over-year decline in Operating Leases has ranged between 6.3% (Q3 2025) and 20.9% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.82 million (Q1 2026), $5.12 million (Q4 2025) and $5.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.52 Mn |
| Mar 31, 2026 | 4.82 Mn |
| Dec 31, 2025 | 5.12 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Dec 31, 2023 | 6.53 Mn |
| Sep 30, 2023 | 6.74 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 7.14 Mn |
| Dec 31, 2022 | 7.37 Mn |
| Sep 30, 2022 | 7.55 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 7.90 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Sep 30, 2021 | 8.23 Mn |
| Jun 30, 2021 | 8.38 Mn |
| Mar 31, 2021 | 8.53 Mn |
API Access
TherapeuticsMD Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();